Drugs / Phosphate-containing Replacement Fluid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07550894 | May 2026 → Dec 2027 expected | acute kidney injury, infectious disease with sepsis | Sun Yat-sen University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phosphate-containing Replacement Fluid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07550894 ↗ |
| Route | Other | “The solution is administered via the extracorporeal circuit during Continuous Renal Replacement Therapy (CRRT).” NCT07550894 ↗ |